1
|
Baur-Bernhardt S, Käsbohrer A, Doherr MG, Meemken D, Sonnenschein-Swanson L, Stetina BU, Sommer MA, Weiermayer P. Assessing the Feasibility of a Two-Cohort Design to Assess the Potential of Homeopathic Medicinal Products to Reduce Antimicrobial Resistance in Turkeys (The HOMAMR Project)-Study Protocol. HOMEOPATHY 2025; 114:50-57. [PMID: 38574753 DOI: 10.1055/s-0044-1781448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/06/2024]
Abstract
BACKGROUND Antimicrobial resistance (AMR) is a serious public health concern worldwide. The European Union requires a reduction in the use of antibiotics by 50% by 2030, with separate regulations on organic production that give preference to homeopathy and phytotherapy in organic farms before the use of conventional medicines (including antibiotics). We have therefore designed a two-phased project whose overarching aim is to investigate the potential role of homeopathic medicinal products (HMPs) in combating AMR in turkeys (the HOMAMR project): a two-cohort feasibility study using turkey-farm data that have been collected and analyzed retrospectively, followed by a prospective two-cohort study in turkey farms that would examine the impact of HMPs on changing antibiotic use. OBJECTIVE The objective of this paper is to describe the protocol for the first phase of HOMAMR, which is a study under field conditions to assess the feasibility of collecting data retrospectively about turkeys that have been managed conventionally only or with HMPs. METHODS Surveys performed on farms in Germany and Austria, including interviews with consenting farmers, will determine the feasibility of comparing retrospectively gathered data on antibiotic use and performance/production data in two cohorts of turkeys: (1) homeopathic treatment with conventional care (antibiotics) added if necessary or (2) conventional care (antibiotics) only. Co-primary outcomes to be studied are the amount of antimicrobial use and production period-related mortality. In addition, other production/performance parameters will be compared between the two treated cohorts. CONCLUSION To our knowledge, this is the first feasibility study on the treatment of turkeys using homeopathy, and whose retrospectively obtained data will inform a prospective study that would examine the impact of HMPs on antibiotic use in commercial turkey raising, fattening and breeding production.
Collapse
Affiliation(s)
- Silvia Baur-Bernhardt
- Department Veterinary Medicine, Institute of Food Safety and Food Hygiene, Freie Universität, Berlin, Germany
| | - Annemarie Käsbohrer
- Unit for Veterinary Public Health and Epidemiology, University of Veterinary Medicine, Vienna, Austria
| | - Marcus Georg Doherr
- Department Veterinary Medicine, Institute for Veterinary Epidemiology and Biostatistics, Freie Universität, Berlin, Germany
| | - Diana Meemken
- Department Veterinary Medicine, Institute of Food Safety and Food Hygiene, Freie Universität, Berlin, Germany
| | - Lena Sonnenschein-Swanson
- Department Veterinary Medicine, Institute of Food Safety and Food Hygiene, Freie Universität, Berlin, Germany
| | | | - Mary-Ann Sommer
- Department Veterinary Medicine, Institute of Food Safety and Food Hygiene, Freie Universität, Berlin, Germany
| | - Petra Weiermayer
- Unit for Veterinary Public Health and Epidemiology, University of Veterinary Medicine, Vienna, Austria
| |
Collapse
|
2
|
Baars EW, Weiermayer P, Szőke HP, van der Werf ET. The Introduction of the Global Traditional, Complementary, and Integrative Healthcare (TCIH) Research Agenda on Antimicrobial Resistance and Its Added Value to the WHO and the WHO/FAO/UNEP/WOAH 2023 Research Agendas on Antimicrobial Resistance. Antibiotics (Basel) 2025; 14:102. [PMID: 39858387 PMCID: PMC11762681 DOI: 10.3390/antibiotics14010102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2024] [Revised: 01/12/2025] [Accepted: 01/15/2025] [Indexed: 01/27/2025] Open
Abstract
Background/Objectives: Given the magnitude and urgency of the global antimicrobial resistance (AMR) problem and the insufficiency of strategies to reduce antimicrobial use, there is a need for novel strategies. Traditional, Complementary, and Integrative Healthcare (TCIH) provides strategies and solutions that contribute to reducing (inappropriate) antimicrobial use, preventing or treating infections in both human and veterinary medicine, and may contribute to promoting the health/resilience of humans and animals and reducing AMR. The aims of this study were to present the core results of a global TCIH research agenda for AMR and its added value to two existing global AMR research agendas published in 2023. Methods: A survey, interviews, and consensus meetings among network members, as an adapted version of the nominal group technique, were executed to develop the global TCIH research agenda. A comparison of the global TCIH research agenda with the two existing global AMR research agendas was performed. The TCIH additions to these two existing global AMR research agendas were determined. Results: The global TCIH research agenda adds to 19 of 40 research priorities of the World Health Organization (WHO) AMR research agenda 2023 and three of the five pillars of the WHO/Food and Agriculture Organization of the United Nations (FAO)/United Nations Environment Programme (UNEP)/World Organisation for Animal Health (WOAH) research agenda 2023. In addition, the TCIH research agenda adds two new research themes with four new research priorities and three new research priorities to already existing themes of the two global AMR research agendas. Conclusions: The global TCIH research agenda fits with and adds to two global AMR research agendas and can be used as an additional strategy to reduce AMR and (inappropriate) use of antibiotics.
Collapse
Affiliation(s)
- Erik W. Baars
- Faculty of Healthcare, University of Applied Sciences Leiden, 2333 CK Leiden, The Netherlands
- Department of Health, Louis Bolk Institute, 3981 AJ Bunnik, The Netherlands
| | - Petra Weiermayer
- WissHom: Scientific Society for Homeopathy, 06366 Koethen, Germany;
- Department of Medicine, University of Witten/Herdecke, 58453 Herdecke, Germany
| | - Henrik P. Szőke
- Department of Integrative Medicine, University of Pécs, 7621 Pécs, Hungary;
| | - Esther T. van der Werf
- Homeopathy Research Institute, London SW7 4EF, UK;
- Bristol Medical School, University of Bristol, Bristol BS8 1UD, UK
| |
Collapse
|
3
|
Weiermayer P, Frass M, Fibert P, Klein-Laansma C, Ulbrich-Zürni S. Recommendations for Designing, Conducting and Reporting Clinical Observational Studies in Homeopathic Veterinary Medicine. HOMEOPATHY 2023; 112:226-239. [PMID: 36929496 PMCID: PMC10586889 DOI: 10.1055/s-0043-1760845] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2022] [Accepted: 12/02/2022] [Indexed: 03/18/2023]
Abstract
BACKGROUND Clinical observational studies are an important methodological approach in human and veterinary research, examining and describing treatment experience with good external validity. There are currently few observational studies in the field of homeopathic veterinary medicine. AIM The aim of the study was to develop recommendations for designing, conducting and reporting observational studies in homeopathic veterinary medicine. MATERIALS AND METHODS A literature review was performed using various search strategies for identifying guidelines and checklist tools relevant for observational studies, veterinary research and homeopathy. Useful guidelines were selected. Prior recommendations for designing and conducting observational studies in human homeopathic medicine were supplemented with recommendations for homeopathic veterinary medicine that were evaluated by an expert panel. RESULTS The veterinary extension of the Strengthening the Reporting of Observational Studies in Epidemiology - Veterinary (STROBE-Vet) statement was identified as a useful tool to improve the reporting quality of observational studies, and it has been supplemented here with additional recommendations that are applicable to homeopathy. STROBE-Vet is complemented in the literature by several reports, checklists and guidelines on veterinary medicine in general, such as the Checklist for One Health Epidemiological Reporting of Evidence (COHERE) and the Animal Health Surveillance Reporting Guidelines (AHSURED). Identified items that related to laboratory animal research were excluded as non-relevant to our study. CONCLUSION Clinical observational studies are an important methodological approach, having currently unrealized potential in the field of homeopathic veterinary medicine. With relatively minor adjustments, the practical guidelines and checklists available to researchers in designing, conducting and reporting observational studies in human homeopathic medicine have been adapted for homeopathic veterinary medicine, for which high quality can be assured by implementing recommendations such as those in STROBE-Vet. With the emergence of the One Health concept, the COHERE checklist can be viewed with growing significance.
Collapse
Affiliation(s)
- Petra Weiermayer
- WissHom: Research Department, Scientific Society for Homeopathy, Köthen, Germany
| | - Michael Frass
- Department of Medicine I (emeritus), Medical University of Vienna, Vienna, Austria
- Institute for Homeopathic Research, Vienna, Austria
| | - Philippa Fibert
- Department of Psychology and Pedagogic Science, St Mary's University, Twickenham, United Kingdom
| | | | - Susanne Ulbrich-Zürni
- WissHom: Scientific Society for Homeopathy, Köthen, Germany
- Institute of Integrative Medicine, University of Witten/Herdecke, Herdecke, Germany
| |
Collapse
|
4
|
Placha I, Bacova K, Plachy L. Current Knowledge on the Bioavailability of Thymol as a Feed Additive in Humans and Animals with a Focus on Rabbit Metabolic Processes. Animals (Basel) 2022; 12:ani12091131. [PMID: 35565557 PMCID: PMC9104011 DOI: 10.3390/ani12091131] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2022] [Revised: 04/22/2022] [Accepted: 04/26/2022] [Indexed: 01/26/2023] Open
Abstract
Simple Summary This review provides general information on the possible health benefits in animals and humans of herbal additives, particularly thymol, whose phenolic group is responsible for the neutralisation of free radicals, and information concerning its detection through body action, bioavailability and mechanisms in rabbits. Plants containing thymol have been used in traditional medicine for the treatment of various diseases, such as cardiovascular diseases, cancer and diabetes. Although a great number of in vitro studies of cardiovascular and cancer diseases are available, in vivo studies that confirm these findings have not been sufficiently reported. To determine the beneficial dose, further clinical studies are necessary, with preclinical comprehensive research on animal models. Abstract The aim of this review is to describe the therapeutic effect of thymol on various human diseases, followed by its bioavailability in humans and animals. Based on our knowledge from the current literature, after thymol addition, thymol metabolites—mostly thymol sulphate and glucuronide—are detected in the plasma and urine of humans and in the plasma, intestinal content, faeces and tissues in rats, pigs, chickens, horses and rabbits after enzymatic cleavage. In rabbits, thymol absorption from the gastrointestinal tract, its distribution within the organism, its accumulation in tissues and its excretion from the organism have been described in detail. It is necessary and important for these studies to suggest the appropriate dose needed to achieve the required health benefits not only for animals but also for humans. Information from this review concerning the mode of action of thymol in animal organisms could also be applied to human medicine and may help in the utilisation of herbal medicine in humans and in veterinary healthcare. This review summarises the important aspects of thymol’s effects on health and its bioavailability in organisms, particularly in rabbits. In future, herbal-based drugs must be extensively investigated in terms of their mode of action, efficiency of administration and clinical effect.
Collapse
Affiliation(s)
- Iveta Placha
- Centre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Soltesovej 4-6, 040 01 Kosice, Slovakia;
- Correspondence: ; Tel.: +421-55-792-2969
| | - Kristina Bacova
- Centre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Soltesovej 4-6, 040 01 Kosice, Slovakia;
- University of Veterinary Medicine and Pharmacy, Komenskeho 73, 041 81 Kosice, Slovakia
| | - Lukas Plachy
- 1st Department of Cardiology, East Slovak Institute of Cardiovascular Diseases, Ondavska 8, 040 11 Kosice, Slovakia;
- Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Trieda SNP 457/1, 040 11 Kosice, Slovakia
| |
Collapse
|
5
|
Mertenat D, Cero MD, Vogl CR, Ivemeyer S, Meier B, Maeschli A, Hamburger M, Walkenhorst M. Ethnoveterinary knowledge of farmers in bilingual regions of Switzerland - is there potential to extend veterinary options to reduce antimicrobial use? JOURNAL OF ETHNOPHARMACOLOGY 2020; 246:112184. [PMID: 31465817 PMCID: PMC7185669 DOI: 10.1016/j.jep.2019.112184] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/06/2019] [Revised: 08/21/2019] [Accepted: 08/22/2019] [Indexed: 05/08/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE In the pre-antibiotic era, a broad spectrum of medicinal plants was used to treat livestock. This knowledge was neglected in European veterinary medicine for decades but kept alive by farmers. Emergence of multidrug resistant bacterial strains requires a severely restricted use of antibiotics in veterinary medicine. We conducted a survey on the ethnoveterinary knowledge of farmers in the bilingual (French and German speaking) Western region of Switzerland, namely the cantons of Fribourg, Neuchâtel and Jura, and in the French speaking part of the canton of Bern. AIM OF THE STUDY To find out whether differences exist in plants used by farmers in French speaking and bilingual regions of Switzerland as compared to our earlier studies conducted in Switzerland. Additional focus was on plants that are used in diseases which commonly are treated with antimicrobials, on plants used in skin afflictions, and on plants used in animal species such as horses, for which the range of veterinary medicinal products is limited. MATERIAL AND METHODS We conducted in 2015 semistructured interviews with 62 dialog partners, mainly cattle keeping farmers but also 18 horse keeping farmers. Of these, 41 were native French (FNS) and 21 native German speakers (GNS). Detailed information about homemade herbal remedies (plant species, plant part, manufacturing process) and the corresponding use reports (target animal species, category of use, route of administration, dosage, source of knowledge, frequency of use, last time of use and farmers satisfaction) were collected. RESULTS A total of 345 homemade remedies were reported, of which 240 contained only one plant species (Homemade Single Species Herbal Remedy Reports; HSHR). A total of 289 use reports (UR) were mentioned for the 240 HSHR, and they comprised 77 plant species belonging to 41 botanical families. Of these, 35 plant species were solely reported from FNS, 20 from GNS, and 22 from both. Taking into account earlier ethnoveterinary studies conducted in Switzerland only 10 (FNS) and 6 (GNS) plant species connected with 7% of FNS and GNS UR respectively were "unique" to the respective language group. The majority of the UR (219) was for treatment of cattle, while 38 UR were intended to treat horses. The most UR were for treatment of gastrointestinal and skin diseases. The most frequently mentioned plants were Linum usitatissimum L., Coffea L., Matricaria chamomilla L., Camellia sinensis (L.) Kuntze, and Quercus robur L. for gastrointestinal diseases, and Calendula officinalis L., Hypericum perforatum L. and Sanicula europaea L. for skin afflictions. CONCLUSION No clear differences were found between the medicinal plants used by French native speakers and German native speakers. Several of the reported plants seem to be justified to widen the spectrum of veterinary therapeutic options in gastrointestinal and dermatological disorders in cattle and horses, and to reduce, at least to a certain degree, the need for antibiotic treatments. Our findings may help to strengthen the role of medicinal plants in veterinary research and practice, and to consider them as a further measure in official strategies for lowering the use of antibiotics.
Collapse
Affiliation(s)
- Doréane Mertenat
- Pharmaceutical Biology, Pharmacenter, University of Basel, Basel, Switzerland
| | - Maja Dal Cero
- University of Zurich, Department of Systematic and Evolutionary Botany, Zürich, Switzerland
| | - Christan R Vogl
- Division of Organic Farming, Department of Sustainable Agricultural Systems, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria
| | - Silvia Ivemeyer
- Farm Animal Behaviour and Husbandry Section, University of Kassel, Kassel, Germany
| | - Beat Meier
- Unit of Phytopharmacy and Natural Product Research, Institute of Chemistry and Biotechnology, Zurich University of Applied Sciences, Wädenswil, Switzerland
| | - Ariane Maeschli
- Department of Livestock Science, Research Institute of Organic Agriculture, Ackerstrasse 113, Postfach, CH-5070, Frick, Switzerland
| | - Matthias Hamburger
- Pharmaceutical Biology, Pharmacenter, University of Basel, Basel, Switzerland.
| | - Michael Walkenhorst
- Department of Livestock Science, Research Institute of Organic Agriculture, Ackerstrasse 113, Postfach, CH-5070, Frick, Switzerland.
| |
Collapse
|
6
|
Walkenhorst M. Neues aus der Veterinärmedizin. Complement Med Res 2019; 26:289-292. [PMID: 31593954 DOI: 10.1159/000503909] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2019] [Accepted: 10/07/2019] [Indexed: 01/24/2023]
Affiliation(s)
- Michael Walkenhorst
- Departement für Nutztierwissenschaften, Forschungsinstitut für biologischen Landbau FiBL, Frick, Schweiz,
| |
Collapse
|